Get the Stockscreener App
337.50
1.65%
5.48
After Hours:
337.59
0.09
+0.03%
Intuitive Surgical Inc stock is traded at $337.50, with a volume of 3.44M.
It is up +1.65% in the last 24 hours and down -16.01% over the past month.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$332.02
Open:
$334.6
24h Volume:
3.44M
Relative Volume:
1.19
Market Cap:
$120.92B
Revenue:
$11.03B
Net Income/Loss:
$3.16B
P/E Ratio:
38.68
EPS:
8.7251
Net Cash Flow:
$3.22B
1W Performance:
-2.29%
1M Performance:
-16.01%
6M Performance:
-35.59%
1Y Performance:
-30.93%
1-Day Range:
$332.15
$341.83
1-Week Range:
$328.57
$362.85
52-Week Range:
$328.57
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
337.50 | 118.96B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 42.15B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 32.78B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 31.82B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 27.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Upgrade | Citigroup | Neutral → Buy |
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Dec-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-23-25 | Downgrade | Erste Group | Buy → Hold |
| Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Intuitive Surgical stock rises on steady da Vinci demand - AD HOC NEWS
Intuitive Surgical Has Lost 45% From Its High. J&J’s New Robot Is Only Part of Why - TIKR.com
Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo - Yahoo Finance
Daiwa Securities Adjusts Price Target on Intuitive Surgical to $360 From $530, Maintains Outperform Rating - marketscreener.com
Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing? - Trefis
Medtech Stocks Have Gotten Slammed. Why Abbott, Danaher, 4 More Are Bargains. - Barron's
Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical - Yahoo Finance
Intuitive Surgical stock holds near record levels on strong margins - Ad-hoc-news.de
Intuitive Surgical stock trades near record territory as robotic surgery growth supports valuation - AD HOC NEWS
Intuitive Surgical Confronts Rising Risks From Unauthorized da Vinci and Ion Parts and Service - The Globe and Mail
2 Top Growth Stocks to Buy Right Now Without Any Hesitation - The Motley Fool
2 Top Growth Stocks to Buy Right Now Without Any Hesitation - The Motley Fool
Intuitive Surgical (ISRG) Earnings Beat Keeps Its Valuation Narrative In Focus - simplywall.st
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors - MarketWatch
J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock. - Yahoo Finance
ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now? - TradingView
The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants - Yahoo! Finance Canada
Intuitive showcases AI for surgical robotics, telesurgery capabilities - MassDevice
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It? - Yahoo Finance
Intuitive to Unveil AI Vision for Surgical Care and Demonstrate Live Telesurgery at SRS Conference - Quiver Quantitative
Intuitive Shares Vision for an AI-Enabled Future of Healthcare - GlobeNewswire
FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’ - Fierce Biotech
Why Did PEGA, ISRG, MCD Stocks Plunge To 52-Week Lows Today? - Stocktwits
Johnson & Johnson announces its entry into the US robotic surgery market, says it is ready to enter hospi - The Times of India
Intuitive Surgical stock trades steadily as da Vinci procedures grow and margins expand - Ad-hoc-news.de
Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker - Yahoo Finance
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today - Barchart.com
Time runs out for Vicarious Surgical - MedTech Dive
The Wait Is Over: J&J's OTTAVA Surgical Robot Wins FDA Nod, Challenging Intuitive's 80% Market Share - Medical Device and Diagnostic industry
Intuitive Surgical (ISRG) investment analysis: fundamentals vs. technicals after the selloff By Investing.com - Investing.com
Johnson & Johnson Enters Robotic Surgery Market; Flagship Device Gets FDA Nod - NDTV Profit
Intuitive Surgical stock hits 52-week low at 342.06 USD By Investing.com - Investing.com South Africa
Intuitive Surgical stock hits 52-week low at 342.06 USD - Investing.com India
Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot - Seeking Alpha
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue - TradingView
ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure - Yahoo Finance
Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise - Yahoo Finance
J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive - MedTech Dive
J&J MedTech jumps into surgical robot game as OTTAVA secures FDA nod - Medical Device Network
Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth? - Yahoo Finance
J&J enters US robotic surgery market after device gets marketing authorization - Reuters
CICC Adjusts Intuitive Surgical Price Target to $389 From $501, Maintains Neutral Rating - marketscreener.com
Conmed’s AirSeal Robotic Solution OK’ed for Intuitive da Vinci 5 Hex Cannula - Medical Product Outsourcing
Johnson & Johnson wins FDA nod for Ottava surgical robot - MassDevice
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal - Business Wire
Intuitive Surgical, Inc. (ISRG) Stock Forecasts - Yahoo! Finance Canada
Even the da Vinci Surgical Robot Has Started to Reduce Costs - 36 Kr
ISRG SWOT Analysis: Strong Financials and Growth Potential Revea - GuruFocus
Intuitive Surgical (ISRG) Files $1.77 Billion ESOP Shelf Registration - simplywall.st
Intuitive Surgical Inc. stock underperforms Friday when compared to competitors - MSN
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.22%
7.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):